Search

Your search keyword '"Creed, T"' showing total 114 results

Search Constraints

Start Over You searched for: Author "Creed, T" Remove constraint Author: "Creed, T"
114 results on '"Creed, T"'

Search Results

6. Activating STING1-dependent immune signaling inTP53mutant and wild-type acute myeloid leukemia

14. P713 Effects of vedolizumab on health-related quality of life, work productivity and patient concerns in patients with ulcerative colitis and Crohn’s disease in the UK and Ireland: OCTAVO cohort 2

15. Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization and impact in ulcerative Colitis)

16. Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial

17. HLA-DQA1–HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants

18. Neutrophil exocytosis induces podocyte cytoskeletal reorganization and proteinuria in experimental glomerulonephritis

19. Reports Of Societies

21. Ustekinumab as induction and maintenance therapy for Crohn's disease

23. The PAX-SIX-EYA-DACH network modulates GATA-FOG function in fly hematopoiesis and human erythropoiesis.

25. Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease

26. Neutrophil exocytosis induces podocyte cytoskeletal reorganization and proteinuria in experimental glomerulonephritis.

31. Frontline Science: Tumor necrosis factor-a stimulation and priming of human neutrophil granule exocytosis

35. Use of risedronate to prevent bone loss following a single course of glucocorticoids: findings from a proof-of-concept study in inflammatory bowel disease

37. Should we monitor vitamin B12 levels in patients who have had end-ileostomy for inflammatory bowel disease?

38. PWE-056 Single centre experience of vedolizumab in the management of moderate to severe ulcerative colitis and crohn’s disease

41. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study

42. Unveiling errors in soil microbial community sequencing: a case for reference soils and improved diagnostics for nanopore sequencing.

43. Multi-label Multi-task Deep Learning for Behavioral Coding.

44. The Structure of Competence: Evaluating the Factor Structure of the Cognitive Therapy Rating Scale.

45. A Non-randomized Comparison of Strategies for Consultation in a Community-Academic Training Program to Implement an Evidence-Based Psychotherapy.

46. Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial.

47. Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease.

48. System-Level Influences on the Sustainability of a Cognitive Therapy Program in a Community Behavioral Health Network.

49. Sexual trauma history does not moderate treatment outcome in Attachment-Based Family Therapy (ABFT) for adolescents with suicide ideation.

50. Increased serum free tryptophan in patients with diarrhea-predominant irritable bowel syndrome.

Catalog

Books, media, physical & digital resources